BY SPNW Staff 03:19PM 09/11/2017

Mariners’ Dyson opts for surgery; season done

CF Jarrod Dyson chose to have abdominal-muscle surgery to fix an injury lingering from August, ending his season. He hit .252 with a career-high five home runs.

Jarrod Dyson led the Mariners with 28 stolen bases. / Alan Chitlik, Sportspress Northwest

CF Jarrod Dyson has opted to have surgery to repair muscle damage in his pelvic region, a procedure that will end Dyson’s season. Mariners manager Scott Servais, speaking to reporters Monday prior to the game against the Texas Rangers in Arlington, described Dyson’s impending surgery as akin to repairing a sports hernia.

“It’s a very minor thing that won’t affect him at all going forward,” said Servais. “But he chose to have it done at this time. He’s obviously done for the season.”

Dyson injured his groin in August during a play in the outfield and was placed on the disabled list Aug. 19. After he was activated, he played in two games, but hasn’t appeared since Sept. 2.

“When he was healthy, he did a lot for us in the outfield, defense-wise, and what he can do on the bases — that’s his game,” Servais said. “Unfortunately, he decided he couldn’t play through it.”

In 111 games, Dyson hit .252 with five home runs and 30 RBIs. He also led the Mariners with 28 stolen bases and had 11 outfield assists and 15 defensive runs saved.

The Mariners acquired Dyson, 32, from Kansas City following the 2016 season for pitcher Nathan Karns. Dyson will become a free agent after this season and is expected to test the market, perhaps one reason why he elected to have surgery rather than attempt to play and possibly aggravate the injury.

The Mariners (71-72) begin a four-game series at 5:05 p.m. PT with LHP Ariel Miranda (8-6, 4.72) throwing for Seattle opposite LHP Cole Hamels (9-3, 4.03). Miranda is 0-1, 6.35 against Texas this season while Hamels is 0-0, 4.91 vs. Seattle.

Seattle began Monday three games behind Minnesota in the race or the second American League wild card slot.


YourThoughts

Comments are closed.